Significantly increased fractions of transformed to total alpha2-macroglobulin concentrations in plasma from patients with multiple sclerosis.

[1]  K. Werdan,et al.  Role of LDL receptor-related protein (LRP) in coronary atherosclerosis. , 2003, International journal of cardiology.

[2]  J. Herz.  LRP: a bright beacon at the blood-brain barrier. , 2003, The Journal of clinical investigation.

[3]  S. Ranganathan,et al.  Diverse role of LDL receptor‐related protein in the clearance of proteases and in signaling , 2003, Journal of thrombosis and haemostasis : JTH.

[4]  P. Sundström,et al.  Native and transformed α2‐macroglobulin in plasma from patients with multiple sclerosis , 2003, Acta neurologica Scandinavica.

[5]  W. Schneider,et al.  LDL receptor relatives at the crossroad of endocytosis and signaling , 2003, Cellular and Molecular Life Sciences CMLS.

[6]  M. Trojano,et al.  Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis subtypes , 2003, Journal of Neuroimmunology.

[7]  A. Vaheri,et al.  Coordinated induction of extracellular proteolysis systems during experimental autoimmune encephalomyelitis in mice. , 2001, The American journal of pathology.

[8]  B. Hyman,et al.  Elevation of LDL Receptor‐Related Protein Levels via Ligand Interactions in Alzheimer Disease and In Vitro , 2001, Journal of neuropathology and experimental neurology.

[9]  T. Stigbrand,et al.  Immunochemical aberrations of α2‐macroglobulin purified from a patient with multiple sclerosis , 2000, Acta neurologica Scandinavica.

[10]  T. Stigbrand,et al.  Conformational variants of human alpha2-macroglobulin are reflected in a C-terminal 'switch region'. , 2000, European Journal of Biochemistry.

[11]  M. Stevens,et al.  INVOLVEMENT OF α-2-MACROGLOBULIN RECEPTOR IN CLEARANCE OF INTERLEUKIN 8–α-2-MACROGLOBULIN COMPLEXES BY HUMAN ALVEOLAR MACROPHAGES , 2000 .

[12]  T. Stigbrand,et al.  Aberrant forms of α2-macroglobulin purified from patients with multiple sclerosis , 2000 .

[13]  T. Stigbrand,et al.  Decreased stability of alpha2-macroglobulin purified from patients with multiple sclerosis. , 2000, Acta neurologica Scandinavica.

[14]  S. L. Gonias,et al.  Interleukin-4 and IL-10 bind covalently to activated human alpha2-macroglobulin by a mechanism that requires Cys949. , 2000, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[15]  P Bacchetti,et al.  Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis. , 1999, Neurology.

[16]  M. Gunnarsson,et al.  Binding of soluble myelin basic protein to various conformational forms of alpha2-macroglobulin. , 1998, Archives of biochemistry and biophysics.

[17]  D. Holtzman,et al.  Nerve Growth Factor Induces Rapid Increases in Functional Cell Surface Low Density Lipoprotein Receptor-related Protein* , 1998, The Journal of Biological Chemistry.

[18]  J. Cossins,et al.  Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions , 1997, Acta Neuropathologica.

[19]  G. Birkenmeier,et al.  Plasma concentration of total and transformed α2-macroglobulin in systemic sclerosis , 1996, Archives of Dermatological Research.

[20]  S. Vandenberg,et al.  Transcriptional regulation of LDL receptor‐related protein by IFN‐γ and the antagonistic activity of TGF‐β1 in the RAW 264.7 macrophage‐like cell line , 1996, Journal of leukocyte biology.

[21]  C. Bever,et al.  Increased cathepsin B activity in multiple sclerosis brain , 1995, Journal of the Neurological Sciences.

[22]  T. Stigbrand,et al.  Methanethiolation of the liberated cysteine residues of human alpha 2-macroglobulin treated with methylamine generates a derivative with similar functional characteristics as native alpha 2-macroglobulin. , 1995, European journal of biochemistry.

[23]  S. Moestrup.  The alpha 2-macroglobulin receptor and epithelial glycoprotein-330: two giant receptors mediating endocytosis of multiple ligands. , 1994, Biochimica et biophysica acta.

[24]  S. L. Gonias,et al.  Classification of alpha 2-macroglobulin-cytokine interactions based on affinity of noncovalent association in solution under apparent equilibrium conditions. , 1994, The Journal of biological chemistry.

[25]  T. Stigbrand,et al.  Production of conformation-specific monoclonal antibodies against α2 macroglobulin and their use for quantitation of total and transformed α2 macroglobulin in human blood , 1993 .

[26]  S. Pizzo,et al.  Receptor-mediated antigen delivery into macrophages. Complexing antigen to alpha 2-macroglobulin enhances presentation to T cells. , 1993, Journal of immunology.

[27]  S. Vandenberg,et al.  Characterization and immunohistochemical localization of alpha 2-macroglobulin receptor (low-density lipoprotein receptor-related protein) in human brain. , 1992, The American journal of pathology.

[28]  S. L. Gonias,et al.  Alpha 2-macroglobulin: a protein at the interface of fibrinolysis and cellular growth regulation. , 1992, Experimental hematology.

[29]  S. L. Gonias,et al.  Cytokine binding and clearance properties of proteinase-activated alpha 2-macroglobulins. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[30]  A. Shaw,et al.  Covalent disulfide binding of human IL-1β to α2-macroglobulin: Inhibition by d-penicillamine☆ , 1991 .

[31]  F. van Leuven,et al.  Alpha 2 macroglobulin state in acute pancreatitis. Raised values of alpha 2 macroglobulin-protease complexes in severe and mild attacks. , 1991, Gut.

[32]  F. van Leuven,et al.  Measurement of the 'fast' or complexed form of alpha 2 macroglobulin in biological fluids using a sandwich enzyme immunoassay. , 1990, Journal of immunological methods.

[33]  S. Pizzo,et al.  Use of anti-idiotypic antibodies to establish that monoclonal antibody 7H11D6 binds to the alpha 2-macroglobulin receptor recognition site. , 1988, The Journal of biological chemistry.

[34]  D. Strickland,et al.  Identification of a monoclonal antibody specific for a neoantigenic determinant on alpha 2-macroglobulin: use for the purification and characterization of binary proteinase-inhibitor complexes. , 1988, Biochemistry.

[35]  S. Pizzo,et al.  Physical properties of human α2-macroglobulin following reaction with methylamine and trypsin , 1982 .

[36]  F. van Leuven,et al.  Functional modifications of alpha 2-macroglobulin by primary amines. I. Characterization of alpha 2 M after derivatization by methylamine and by factor XIII. , 1981, The Journal of biological chemistry.

[37]  S. Pizzo,et al.  Clearance and binding of two electrophoretic "fast" forms of human alpha 2-macroglobulin. , 1981, The Journal of biological chemistry.

[38]  A. Barrett,et al.  The electrophoretically 'slow' and 'fast' forms of the alpha 2-macroglobulin molecule. , 1979, The Biochemical journal.

[39]  M. Cuzner,et al.  Proteolytic enzyme activity of blood leukocytes and cerebrospinal fluid in multiple sclerosis , 1978, Annals of neurology.

[40]  W. Rapp,et al.  [Methods for the quantitative determination of plasma proteins by immunoprecipitation]. , 1968, Zeitschrift fur klinische Chemie und klinische Biochemie.

[41]  E. Chambaz,et al.  Alpha 2-macroglobulin: a binding protein for transforming growth factor-beta and various cytokines. , 1996, Hormone research.

[42]  Banik Nl.  Pathogenesis of myelin breakdown in demyelinating diseases: role of proteolytic enzymes. , 1992 .

[43]  K. James.  Interactions between cytokines and α2-macroglobulin , 1990 .

[44]  B. Scherstén,et al.  Serum α2-macroglobulin concentration and its variation with age and sex , 1967 .